✦ LIBER ✦

Phase I study of ftorafur, an analog of 5-fluorouracil

✍ Scribed by Charles R. Smart; Leroy B. Townsend; William J. Rusho; Harmon J. Eyre; Joseph M. Quagliana; Merrill L. Wilson; Charles B. Edwards; Steven J. Manning

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 278 KB
Volume: 36
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197507)36:1<103::aid-cncr2820360106>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of protracted venous infus

Phase I study of protracted venous infusion of 5-fluorouracil

✍ J. Lokich; A. Bothe; N. Fine; J. Perri 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Phase I-II study of ftorafur and methyl-

Phase I-II study of ftorafur and methyl-ccnu in advanced colorectal cancer

✍ Robert J. Belt; Ronald Stephens 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

The combination of Ftorafur (NSC-148958) and methyl-CCNU (NSC-95441) was evaluated in 36 patients with advanced colorectal cancer. The principle toxicities encountered were myelosuppression, gastrointestinal, and neurological. There were no complete responses and only 5/34 (14.7%) patients achieved

A phase I–II study of epirubicin, 5-fluo

A phase I–II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach

✍ Gabriela Kornek; Franz Schulz; Dieter Depisch; Harald Rosen; Werner Kwasny; Chri 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 2 views

Phase I study of 5-fluorouracil administ

Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy

✍ James A. Martenson; Thomas G. Shanahan; Michael J. O'Connell; Charles D. Cobau; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## BACKGROUND. This study was designed to assess the toxicity of pelvic radiation therapy, 5-fluorouracil (5-FU) administered by protracted venous infusion, and leucovorin. ## METHODS. Pelvic radiation therapy consisted of 50.4 -54 gray (Gy) administered in 28 -30 fractions. Systemic treatment

Continuous infusion 5-fluorouracil with

Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study

✍ Thomas Saphner; Douglass C. Tormey; Mark Albertini 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 2 views

Dual modulation of 5-fluorouracil using

Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial

✍ J. Lokich; N. Anderson; M. Bern; F. Coco; T. Zipoli; C. Moore; L. Gonsalves 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 1 views

Oral hydroxyurea (HU) was added to a regimen of 5-fluorouracil(5-FU) plus leucovorin (LCV) administered as a continuous 24-hour infusion for 14 days. A previous report of the 5-FU plus LCV infusion established optimal dosages of 200 mg/mz/d and 5 mg/mz/d, respectively, for each agent. Oral HU was ad